Background: A pathological complete response (pCR) after neoadjuvant chemotherapy
(NCT) is a strong indicator of the benefit of therapy and presents an early surrogate for a …

Abstract Context and Objective: There has been increased attention to the issue of fertility
preservation (FP). We aimed to investigate the long-term safety of FP via controlled ovarian …

The introduction of trastuzumab into routine clinical practice has had a dramatic effect on the
outlook for patients with HER2-positive breast cancer. Nevertheless, answers to some long …

Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We
assessed the impact of body mass index (BMI) on pathological complete response (pCR) …

Objectives: Recent studies have shown strong correlation of pathologic complete response
(pCR) to neoadjuvant chemotherapy with survival and prognosis in breast cancers …

Purpose To identify dynamic optical imaging features that associate with the degree of
pathologic response in patients with breast cancer during neoadjuvant chemotherapy …

To identify markers of non-response to neoadjuvant chemotherapy (NAC) that could be used
in the adjuvant setting. Sixteen pathologists of the European Working Group for Breast …

Breast cancer is the most frequently diagnosed malignancy amongst females worldwide. In
recent years the management of this disease has transformed considerably, including the …

Purpose Neoadjuvant systemic therapy (NAC) is currently used in the treatment of stage II/III
breast cancer. Pathological complete response as a surrogate endpoint for clinical …

Purpose The aim of this study was to examine molecular subtype conversions in patients
who underwent neoadjuvant chemotherapy (NAC) and analyze their clinical implications …